Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology Convergence
| UAPSX Fund | USD 52.80 0.49 0.92% |
Slightly above 62% of Ultrasmall Cap's investor base is looking to short. The analysis of overall sentiment of trading Ultrasmall Cap Profund Ultrasmall Cap mutual fund suggests that many investors are alarmed at this time. Ultrasmall Cap's investing sentiment can be driven by a variety of factors including economic data, Ultrasmall Cap's earnings reports, geopolitical events, and overall market trends.
Ultrasmall |
Nektar Therapeutics today announced its oral presentation highlighting preclinical data on NKTR-422 at the 2024 American College of Rheumatology conference, being held in Washington, D.C. from November 14-19, 2024.
Read at finance.yahoo.com
 |
Ultrasmall Cap Fundamental Analysis
We analyze Ultrasmall Cap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ultrasmall Cap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ultrasmall Cap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Ultrasmall Cap is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Ultrasmall Cap Profund Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ultrasmall Cap mutual fund to make a market-neutral strategy. Peer analysis of Ultrasmall Cap could also be used in its relative valuation, which is a method of valuing Ultrasmall Cap by comparing valuation metrics with similar companies.
Peers
Ultrasmall Cap Related Equities
| SRPSX | Short Real | 1.79 | ||||
| SRPIX | Short Real | 1.64 | ||||
| UIPIX | Ultrashort Mid | 0.46 | ||||
| UIPSX | Ultrashort Mid | 0.45 | ||||
| BRPSX | Bear Profund | 0.1 | ||||
| LGPIX | Large Cap | 0.09 | ||||
| BRPIX | Bear Profund | 0.09 | ||||
| LGPSX | Profunds Large | 0.09 | ||||
| TEPIX | Technology Ultrasector | 0.02 | ||||
| TEPSX | Technology Ultrasector | 4.77 |
Other Information on Investing in Ultrasmall Mutual Fund
Ultrasmall Cap financial ratios help investors to determine whether Ultrasmall Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ultrasmall with respect to the benefits of owning Ultrasmall Cap security.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |